Impact of COVID-19: Animal Model Market
The COVID-19 pandemic had a notable impact on the Animal Model Market. The urgent need for vaccines and therapeutics accelerated the development and use of animal models to study SARS-CoV-2 infection, transmission, and immune responses.
Researchers rapidly developed transgenic mouse models and non-human primate models to simulate human infection, facilitating preclinical testing of vaccines and antiviral drugs. This surge in demand highlighted the critical role of animal models in responding to global health emergencies.
However, the pandemic also disrupted supply chains and laboratory operations temporarily, causing delays in non-COVID-related research.
Overall, COVID-19 underscored the importance of the animal model market in accelerating medical research and preparedness for future pandemics.